Evidence map›Paper›PMID 24066347›Full record

ArticleThe International journal of oral & maxillofacial implants

Intraoral grafting of tissue-engineered human oral mucosa.

Kenji Izumi, Rodrigo F Neiva, Stephen E Feinberg

Abstract readEvaluation Study
In one paragraph

Article in The International journal of oral & maxillofacial implants. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 1 pooled it
3.8field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 1 synthesis or guideline pooled it, 64 citations in OpenAlex.

  1. Pooled it
  2. Reconstruction of functional human lips utilizing a prelaminated flap.Frontiers in bioengineering and biotechnology · 2024
    Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Regulatory mechanism of oral mucosal rete peg formation.Journal of molecular histology · 2021
    Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Soft tissue engineering in craniomaxillofacial surgery.Annals of maxillofacial surgery · 2014
    Review
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 3 countries.

Kenji Izumi
Rodrigo F Neiva
Stephen E Feinberg
National Medical Research Center of Dentistry and Maxillofacial Surgery · RUNiigata University · JPUniversity of Florida · US

Funding

ZINC GLUCONATE GLYCINE LOZENGES &VITAMIN C EFFECTS ON COMMON COLDM01RR000042 · NCRR · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI RUBENFIRE, MELVYN · 1985 to 2007
$40.8M
EX VIVO DEVELOPMENT OF TRANSFECTED ORAL MUCOSAL GRAFTSR01DE013417 · NIDCR · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI FEINBERG, STEPHEN ELLIOTT · 2000 to 2009
$2.9M
NCRR NIH HHS M01 RR000042NCRR NIH HHS M01 RR00042NIDCR NIH HHS DE 13417NIDCR NIH HHS R01 DE013417
6 · The paper itself

Abstract

purposeThe primary objective of this study was to evaluate the safety of a tissue-engineered human ex vivo-produced oral mucosa equivalent (EVPOME) in intraoral grafting procedures. The secondary objective was to assess the efficacy of the grafted EVPOME in producing a keratinized mucosal surface epithelium. MATERIALS AND

methodsFive patients who met the inclusion criteria of having one mucogingival defect or a lack of keratinized gingiva on a nonmolar tooth, along with radiographic evidence of sufficient interdental bone height, were recruited as subjects to increase the width of keratinized gingiva at the defect site. A punch biopsy specimen of the hard palate was taken to acquire oral keratinocytes, which were expanded, seeded, and cultured on an acellular dermal matrix for fabrication of an EVPOME. EVPOME grafts were applied directly over an intact periosteal bed and secured in place. At baseline (biopsy specimen retrieval) and at 7, 14, 30, 90, and 180 days postsurgery, Plaque Index and Gingival Index were recorded for each subject. In addition, probing depths, keratinized gingival width, and keratinized gingival thickness were recorded at baseline, 30, 90, and 180 days.

resultsNo complications or adverse reactions to EVPOME were observed in any subjects during the study. The mean gain in keratinized gingival width was 3 mm (range, 3 to 4 mm). The mean gain in keratinized gingival thickness was 1 mm (range, 1 to 2 mm). No significant changes in probing depths were observed.

conclusionBased on these findings, it can be concluded that EVPOME is safe for intraoral use and has the ability to augment keratinized tissue around teeth. Future clinical trials are needed to further explore this potential.

Indexed as

FemaleGingivaGingival DiseasesHumansKeratinocytesMaleMiddle AgedMouth MucosaMucous MembranePilot ProjectsTissue Engineering

Identifiers

PMID24066347
PMCPMC4193471
OpenAlexW2051760139

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.